This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
 
What to Watch on Wall Street for Tuesday, September 16th 2014

In today's "What to Watch on Wall Street" segment for Tuesday, Sept. 16th 2014, we tell you about the two-day Federal Open Market Committee meeting.

Molson Coors Benefits From Beer Industry Acquisition Brouhaha

Shares of Molson Coors spiked on Monday making it TheStreet's Move of the Day.

RadioShack CFO Resigns Amid Murky Outlook and Bankruptcy Worry

RadioShack shares moved higher on Monday after CFO John Feray announced he was leaving the company after just seven months on the job.

Sony Pictures' Low Budget 'No Good Deed' Tops Box Office

The low-budget 'No Good Deed' nearly doubled it's budgeted worth in its opening weekend, making $24.5 million in ticket sales.

U.S. Stocks Close Mixed with Nasdaq Slammed by Sell-off

U.S. stocks closed mixed Monday. The Dow Jones Industrial managed to eek out a small gain while the S&P 500 was little changed in the red.

Real Money Previews

Jim Cramer on Grocery Stocks: Whole Foods Is Easy to Swallow

Those shelving the stock should consider putting it in their basket.

Risks for an Early Fall; 10-Year Yield Watch: Best of Kass

In highlights from his trading diary of the past week, Doug Kass writes about the risk accumulation for the fall and about expectations for 10-year U.S. notes.

Investing's Dirty Word; Do Your Homework: Jim Cramer's Best Blogs

Catch up on Jim Cramer's thinking over the last week about getting through the next week and the vital nature of research.

Mad Money Recap

'Mad Money' Lightning Round: Buy, Buy, Buy St Jude Medical

Cramer likes Alkermes, says hold on to Zynga but wants you to avoid SolarWinds.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

3 Huge Stocks Grabbing Headlines -- and How to Trade them

Here's how to trade some of the most active stocks on the market right now.

How to Trade the Market's Most-Active Stocks: RATE, AVNR, NPSP, TAP

Here's a look at how to trade some of the most active stocks on the market right now.

4 Stocks Breaking Out on Unusual Volume

These stocks risign on unusual volume are within range of triggering breakout trades.

5 Stocks Spiking on Big Volume

Keep these stocks rising on unusual volume on your trading radar.

5 Rocket Stocks Worth Buying in September

These stocks have both short-term gain catalysts and longer-term growth potential.

MainStreet

Promoting Financial Health at Work Can Make Employees More Productive

Health benefits at work can mean more than just your typical PPO plans and co-pays.

Marriott Wants You to Help Pay Staff’s Low Wages, Adds Tip Envelope for Maid

Marriott guests will soon find a new feature in their rooms: a gentle reminder to tip the staff.

Who Will Be Voting on Cannabis Reform This November? Pot Elections Arrive

With the November midterm elections now less than two months away, the tally of states that will be deciding on some kind of voter-driven state marijuana reform is now set.

How to Loan, Borrow and Repay Money From Family Without Awkwardness

Money dealings with friends and family are inherently awkward. Here's how to do it right.

Warren Student Loan Refinance Bill on Tap Before Mid-Term Election

A Senate bill that will allow the re-financing of older, higher interest student loans is set to be reintroduced by Senators Elizabeth Warren (D-Mass.) and Jack Reed (D-R.I.).

Biotech

Avanir's Over-Priced Cough Syrup Touted for Role in Alzheimer's Agitation

Avanir Pharmaceuticals are surging Monday after demonstrating once again that cough syrup produces a nice, mellow high

NPS Pharma Hormone Drug Wins Shaky Endorsement From FDA Panel

NPS Pharmaceuticals shares are weak Monday following a rough outing for its hormone replacement therapy Natpara at an FDA advisory panel on Friday.

Third Time Was No Charm, FDA Denies Amarin Vascepa SPA Appeal

Amarin evaluating next steps following FDA's decision to denial reinstatement of Vascepa SPA for 'Anchor" indication.

Beyond Wall St.

Deal News

Freshpet Files for IPO as Spending on Natural Food for Pets Rises

Freshpet, the Secaucus, N.J.-based maker of natural refrigerated pet food, filed for a $100 million initial public offering.

Molson Coors Benefits From Beer Industry Acquisition Brouhaha

Shares of Molson Coors spiked on Monday making it TheStreet's Move of the Day.

Heineken's Rebuff of SABMiller Won't Stop Beer Industry Consolidation

The Heineken family doesn't want to sell its multinational brewing operations, but a recent spate of beer acquisitions suggests more buyouts ahead.

TheStreetTV
Spin Space

Jim Cramer

Jim Cramer Says the Fed Should Do Nothing When it Meets This Week

Jim Cramer says the Fed should do nothing because rates are already creeping up and they will go higher by themselves as a matter of course.

Herb Greenberg

Greenberg: RadioShack's Pathetic Spin Attempt in the Fine Print

The company has buried its liquidation talk.

Stephanie Link

Dicker/Link: The Very Bad Energy Sector – Is There Anything Worth Buying Yet?

Dan Dicker, Energy contributor at thestreet.com talks with Stephanie Link, co-portfolio director of Action Alerts Plus about the relative weakness of the energy complex and the rel...

Chris Ciaccia

How Facebook Can Generate More Ad Revenue at Higher Prices

As advertising dollars move online, Facebook continues to take share away from traditional methods. And as Facebook gets bigger, it could generate more revenue at higher prices.

Adam Feuerstein

Avanir's Over-Priced Cough Syrup Touted for Role in Alzheimer's Agitation

Avanir Pharmaceuticals are surging Monday after demonstrating once again that cough syrup produces a nice, mellow high

Dan Freed

The Threat From Europe for Visa, MasterCard and the Banks

A decision by Europe's highest court could have big implications for the U.S. business of banks and credit card companies.

Ted Reed

Note to Malaysia Airlines: Call In an Expert to Fix This Mess

Since March, everything has gone wrong for Malaysia Airlines, which lost 510 passengers, 27 crew members and two airplanes in two oddball fatal crashes.

Leon Lazaroff

Labor Day Blues Show Jobs Don't Pay Like They Once Did

Regardless of income, employee salaries for the first half of 2014 declined for most U.S. workers, according to a study by the Washington-based Economic Policy Institute.

Submit an article to us!
DOW 17,007.64 -23.50 -0.14%
S&P 500 1,984.13 -1.41 -0.07%
NASDAQ 4,518.9020 -48.6960 -1.07%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs